These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6509438)

  • 1. Urinary excretion of 3-hydroxy-benzo[a]pyrene after percutaneous penetration and oral absorption of benzo[a]pyrene in rats.
    Jongeneelen FJ; Leijdekkers CM; Henderson PT
    Cancer Lett; 1984 Dec; 25(2):195-201. PubMed ID: 6509438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excretion of 3-hydroxy-benzo(a)pyrene and mutagenicity in rat urine after exposure to benzo(a)pyrene.
    Jongeneelen FJ; Leijdekkers CM; Bos RP; Theuws JL; Henderson PT
    J Appl Toxicol; 1985 Oct; 5(5):277-82. PubMed ID: 3902943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of aloe, aloesin, or propolis on the pharmacokinetics of benzo[a]pyrene and 3-OH-benzo[a]pyrene in rats.
    Cao D; Yoon CH; Shin BS; Kim CH; Park ES; Yoo SD
    J Toxicol Environ Health A; 2005 Dec; 68(23-24):2227-38. PubMed ID: 16326436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of benzo[a]pyrene metabolites following intravenous, oral, and cutaneous benzo[a]pyrene administration.
    Bouchard M; Viau C
    Can J Physiol Pharmacol; 1997 Mar; 75(3):185-92. PubMed ID: 9164700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3-Hydroxybenzo(a)pyrene as a biomarker of dermal exposure to benzo(a)pyrene.
    Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Wathier L; Ferrari E
    Arch Toxicol; 2009 Sep; 83(9):873-83. PubMed ID: 19526226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous absorption of [7.10-14C]benzo[a]pyrene and [7,12-14C]dimethylbenz[a]anthracene in mice.
    Sanders CL; Skinner C; Gelman RA
    Environ Res; 1984 Apr; 33(2):353-60. PubMed ID: 6325143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion kinetics of pyrene and benzo(a)pyrene metabolites following intravenous administration of the parent compounds or the metabolites.
    Bouchard M; Viau C
    Toxicol Appl Pharmacol; 1996 Aug; 139(2):301-9. PubMed ID: 8806846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and excretion of benzo[a]pyrene in the rabbit.
    Chipman JK; Bhave NA; Hirom PC; Millburn P
    Xenobiotica; 1982 Jun; 12(6):397-404. PubMed ID: 6291260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzo(a)pyrenediolepoxide-hemoglobin adducts and 3-hydroxy-benzo(a)pyrene urinary excretion profiles in rats subchronically exposed to benzo(a)pyrene.
    Bouchard M; Viau C
    Arch Toxicol; 1995; 69(8):540-6. PubMed ID: 8534197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous absorption of 7, 10 14C-benzo[a]pyrene and 7, 12 14C-dimethylbenz[a]anthracene in mice.
    Sanders CL; Skinner C; Gelman RA
    J Environ Pathol Toxicol Oncol; 1986; 7(1-2):25-34. PubMed ID: 3098955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of benzo[a]pyrene-Gua adduct in the urine of benzo[a]pyrene-treated rats.
    Autrup H; Seremet T
    Chem Biol Interact; 1986 Nov; 60(2):217-26. PubMed ID: 3791489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excretion kinetics of urinary 3-hydroxybenzo[a]pyrene following dietary exposure to benzo[a]pyrene in humans.
    Chien YC; Yeh CT
    Arch Toxicol; 2012 Jan; 86(1):45-53. PubMed ID: 21785897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excretion of benzo[a]pyrene and metabolites in urine and feces of rats: influence of route of administration, sex and long-term ethanol treatment.
    van de Wiel JA; Fijneman PH; Duijf CM; Anzion RB; Theuws JL; Bos RP
    Toxicology; 1993 Jun; 80(2-3):103-15. PubMed ID: 8327994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of absorption, metabolism kinetics and DNA-binding of intratracheally administered benzo[a]pyrene in the isolated, perfused rat lung: a comparative study between microcrystalline and particulate adsorbed benzo[a]pyrene.
    Törnquist S; Wiklund L; Toftgård R
    Chem Biol Interact; 1985 Jul; 54(2):185-98. PubMed ID: 4028288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of 3-OHB[a]P and (+)-anti-BPDE as biomarkers of B[a]P exposure in rats.
    Lin Q; Xiao-Chen L; Bo Y; Na L; Min S; Gang C; Hui L; Jie Z; Fa-Sheng L
    Biomed Chromatogr; 2016 Mar; 30(3):474-83. PubMed ID: 26230188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary metabolites of benzo[a]pyrene: 3-hydroxy-trans-7,8-dihydro-7,8-dihydroxybenzo[a]pyrene, a biliary metabolite of 3-hydroxybenzo[a]pyrene in the rat.
    Ribeiro O; Kirkby CA; Hirom PC; Millburn P
    Carcinogenesis; 1985 Oct; 6(10):1507-11. PubMed ID: 3876175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous absorption of benzo[a]pyrene in the rat: comparison of in vivo and in vitro results.
    Yang JJ; Roy TA; Mackerer CR
    Toxicol Ind Health; 1986 Dec; 2(4):409-16. PubMed ID: 3590196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-label high-performance liquid chromatographic assay for femtomole levels of benzo[a]pyrene metabolites.
    Murphy SE; Hecht SS
    Anal Biochem; 1985 May; 146(2):442-7. PubMed ID: 4025808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-cyclodextrin reduces bioavailability of orally administered [3H]benzo[a]pyrene in the rat.
    Westerberg G; Wiklund L
    J Pharm Sci; 2005 Jan; 94(1):114-9. PubMed ID: 15761935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.